Bilateral primary renal lymphoma
Inappropriate antidiuretic hormone production in diffuse large B-cell lymphoma
The role of NF-κB in lymphoid malignancies
Refractory immune thrombocytopenic purpura
Recent advances in the understanding of inherited sideroblastic anaemia
Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma
High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia
Serum autotaxin measurement in haematological malignancies
High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes
Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis
Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome
Rivaroxaban – an oral, direct Factor Xa inhibitor – has potential for the management of patients with heparin-induced thrombocytopenia
Treating TTP/HUS with plasma exchange
Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease
Haemophilia A mutations in the UK
Haem-regulated eIF2α kinase is necessary for adaptive gene expression in erythroid precursors under the stress of iron deficiency
Hb Southern Italy
The spleen in beta thalassaemia minor
More studies are needed to assess the performance of serum free light chain measurement for the diagnosis of B-cell disorders in routine clinical practice
More studies are needed to assess the performance of serum free light chain measurement for the diagnosis of B-cell disorders in routine clinical practice
IgM myeloma
Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma